Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men

Metabolism: Clinical and Experimental

Volumn 61, Issue 8, 2012, Pages 1182-1188

  Kim, Chan Won ^a   Chang, Yoosoo ^a   Sung, Eunju ^a   Shin, Hocheol ^a   Ryu, Seungho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

alanine aminotransferase; ALT; aspartate aminotransferase; AST; BMI; body mass index; C reactive protein; CRP; fasting blood glucose; FBG; gamma glutamyltransferase; GGT; HDL; high density lipoprotein; HOMA IR; LDL; low density lipoprotein; metabolic syndrome; MetS; NAFLD; non alcoholic fatty liver disease; the homeostasis model assessment of insulin resistance; ultrasound; US

Indexed keywords

FERRITIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; EXERCISE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING;

ADULT; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FATTY LIVER; FERRITINS; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84864287523     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.01.007     Document Type: Article

References (52)

1. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
2. S. Bellentani, G. Saccoccio, and F. Masutti Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117 (Pubitemid 30044177)
3. J.D. Browning, L.S. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395 (Pubitemid 39657013)
4. J.G. Fan, J. Zhu, and X.J. Li Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 43 2005 508 514 (Pubitemid 41111434)
5. D. Amarapurkar, P. Kamani, and N. Patel Prevalence of non-alcoholic fatty liver disease: population based study Ann Hepatol 6 2007 161 163 (Pubitemid 350277193)
6. E. Bugianesi, N. Leone, and E. Vanni Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140 (Pubitemid 34747534)
7. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
8. G. Marchesini, S. Moscatiello, and S. Di Domizio Obesity-associated liver disease J Clin Endocrinol Metab 93 2008 S74 80
9. H.J. Kim, K.E. Lee, and D.J. Kim Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults Arch Intern Med 164 2004 2169 2175
10. L. Valenti, A.L. Fracanzani, E. Bugianesi, P. Dongiovanni, E. Galmozzi, and E. Vanni HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
11. E. Bugianesi, P. Manzini, and S. D'Antico Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology 39 2004 179 187 (Pubitemid 38461480)
12. K.V. Kowdley, P. Belt, and L.A. Wilson Elevated serum ferritin is an independent predictor of histologic severity and advanced fibrosis among patients with nonalcoholic fatty liver disease Hepatology 2011
13. D.K. George, S. Goldwurm, and G.A. MacDonald Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311 318 (Pubitemid 28093538)
14. K.V. Kowdley The role of iron in nonalcoholic fatty liver disease: the story continues Gastroenterology 138 2010 817 819
15. T.J. Hsiao, J.C. Chen, and J.D. Wang Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients Int J Obes Relat Metab Disord 28 2004 167 172
16. S. Zelber-Sagi, D. Nitzan-Kaluski, and Z. Halpern NAFLD and hyperinsulinemia are major determinants of serum ferritin levels J Hepatol 46 2007 700 707 (Pubitemid 46400138)
17. C. Loguercio, V. De Girolamo, and I. de Sio Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects J Hepatol 35 2001 568 574 (Pubitemid 33078265)
18. J.M. Rumberger, T. Peters Jr., and C. Burrington Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes Diabetes 53 2004 2535 2541 (Pubitemid 39299259)
19. S.P. Wolff Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications Br Med Bull 49 1993 642 652 (Pubitemid 23243836)
20. C.Z. Larter, S. Chitturi, and D. Heydet A fresh look at NASH pathogenesis. Part 1: the metabolic movers J Gastroenterol Hepatol 25 2010 672 690
21. A.J. Sanyal AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 2002 1705 1725 (Pubitemid 35231670)
22. J.M. Clark, and A.M. Diehl Defining nonalcoholic fatty liver disease: implications for epidemiologic studies Gastroenterology 124 2003 248 250 (Pubitemid 36055357)
23. B.R. Bacon, P.C. Adams, and K.V. Kowdley Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 2011 328 343
24. S. Ryu, Y. Chang, and S.G. Kim Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men Metabolism 60 2011 860 866
25. Y. Chang, S. Ryu, and E. Sung Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease Clin Chem 53 2007 686 692 (Pubitemid 46580239)
26. U.L. Mathiesen, L.E. Franzen, and H. Aselius Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases Dig Liver Dis 34 2002 516 522 (Pubitemid 34830694)
27. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
28. WHO Western Pacific Region IaI The Asia-Pacific perspective: redefining obesity and its treatment 2000 Health Communications Australia Pty Limit Sydney, Australia
29. C.P. Wen, T.Y. David Cheng, and S.P. Tsai Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians Public Health Nutr 12 2009 497 506
30. B.K. Lee, Y. Kim, and Y.I. Kim Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008 Metabolism 60 2011 1416 1424
31. A.M. Konijn Iron metabolism in inflammation Bailliere's Clin Haematol 7 1994 829 849
32. P. Arosio, R. Ingrassia, and P. Cavadini Ferritins: a family of molecules for iron storage, antioxidation and more Biochimica et Biophysica Acta 1790 2009 589 599
33. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
34. J.L. Kuk, and C.I. Ardern Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32 2009 2297 2299
35. P. Manousou, G. Kalambokis, and F. Grillo Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients Liver Int 31 2011 730 739
36. K. Tomita, G. Tamiya, and S. Ando Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice Gut 55 2006 415 424 (Pubitemid 43268283)
37. N. Mendez-Sanchez, M. Arrese, and D. Zamora-Valdes Current concepts in the pathogenesis of nonalcoholic fatty liver disease Liver Int 27 2007 423 433 (Pubitemid 46534563)
38. A. Ceriello, and E. Motz Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 2004 816 823 (Pubitemid 38620857)
39. M. Haap, A. Fritsche, and H.J. Mensing Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people Ann Intern Med 139 2003 869 871
40. K.F. Petersen, S. Dufour, and D.B. Savage The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome Proc Natl Acad Sci U S A 104 2007 12587 12594 (Pubitemid 47255198)
41. C. Holm, T. Osterlund, and H. Laurell Molecular mechanisms regulating hormone-sensitive lipase and lipolysis Annu Rev Nutr 20 2000 365 393
42. K.L. Donnelly, C.I. Smith, and S.J. Schwarzenberg Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351 (Pubitemid 40629054)
43. S. Rigazio, H.R. Lehto, and H. Tuunanen The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans Am J Physiol Endocrinol Metab 295 2008 E413 E419
44. L. Valenti, S. Moscatiello, and E. Vanni Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling - a propensity score-adjusted observational study QJM 104 2011 141 149
45. P. Casanova-Esteban, and N. Guiral Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis Metabolism 60 2011 830 834
46. R. Hernaez, M. Lazo, and S. Bonekamp Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis Hepatology 2011
47. S. Ryu, and Y. Chang Kim DI, et al. gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men Clin Chem 53 2007 71 77 (Pubitemid 46055179)
48. H. Yki-Jarvinen Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data Curr Opin Clin Nutr Metab Care 13 2010 709 714
49. M. Jehn, J.M. Clark, and E. Guallar Serum ferritin and risk of the metabolic syndrome in U.S. adults Diabetes Care 27 2004 2422 2428 (Pubitemid 39281396)
50. Y. Shiono, R. Ikeda, and H. Hayashi C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan Intern Med 40 2001 852 856
51. A.T. Merryweather-Clarke, and J.J. Pointon Global prevalence of putative haemochromatosis mutations J Med Genet 34 1997 275 278 (Pubitemid 27208030)
52. J.Y. Lee, K.H. Yoo, and S.H. Hahn HFE gene mutation, C282Y causing hereditary hemochromatosis in Caucasian is extremely rare in Korean population J Korean Med Sci 15 2000 179 182